Contradicting some earlier studies, new research using data from the very large and long-running Nurses' Health Study has found that calcium supplement intake was not associated with a higher risk of cardiovascular disease in women.
http://www.eurekalert.org/pub_releases/2014-05/bawh-csn050914.php
A year-long study involving young adults has compared those who engaged in either tai chi or brisk walking or no exercise. Those who practiced tai chi had a significantly higher number of CD 34+ cells compared with those in the other groups. CD 34+ cells are markers for blood stem cells involved in cell self-renewal, differentiation and proliferation. The findings suggest tai chi may prompt vasodilation and increase blood flow.
http://www.eurekalert.org/pub_releases/2014-05/ctco-ctc052814.php
Blocking a receptor involved in inflammation in the brains of mice with severe Alzheimer’s produced marked recovery in blood flow and vascular reactivity, a dramatic reduction in toxic amyloid-beta, and significant improvements in learning and memory.
The receptor was the bradykinin B1 receptor (B1R), and the finding confirms a role of B1R, and neuroinflammation, in the development of Alzheimer’s. It also points to a new target for therapy.
A new U.S. study suggests that Alzheimer's disease and other dementias are markedly under-reported on death certificates and medical records. Death certificates tend to only provide an immediate cause, such as pneumonia, and don’t mention the underlying condition that provoked it.
A long-running study comparing African-Americans and Nigerians has found the incidence of dementia has fallen significantly over two decades among the African-Americans, but remained the same for the Nigerians (for whom it was lower anyway).
The study enrolled two cohorts, one in 1992 and one in 2001, who were evaluated every 2–3 years until 2009. The 1992 cohort included 1440 older African-Americans (70+) and 1774 Nigerian Yoruba; the 2001 cohort included 1835 African-Americans and 1895 Yoruba. None of the participants had dementia at study beginning.
After Alzheimer's disease, the next most common type of dementia is Lewy Body disease. Far less widely known, this form of dementia is often diagnosed quite late. A new study has validated a simple rating scale that non-specialist clinicians can use to quickly and effectively diagnose LBD in about three minutes.
The Lewy Body Composite Risk Score (LBCRS) is a simple, one-page survey with structured yes/no questions for six non-motor features that are present in patients with LBD, but are much less commonly found in other forms of dementia.
In Australia, it has beens estimated that 9% of people aged over 65, and 30% of those aged over 85 have dementia. However, these estimates are largely based on older data from other countries, or small local samples.
There has been quite a lot of research into the relationship between students’ expectations and academic performance. It’s fairly well-established that students tend to have inflated expectations of their performance, but the effect of this has been disputed. Does over-confidence discourage students from preparing for exams, or do high expectations motivate students to study harder? A largish study has investigated this question.
A large Chinese study involving 20,000 people has found that the longer people were exposed to air pollution, the worse their cognitive performance in verbal and math tests. The effect of air pollution on verbal tests became more pronounced with age, especially for men and the less educated.
The study followed the participants from 2010 to 2014, meaning that the same individuals could be assessed as air pollution varied from one year to the next.
The findings add to previous research showing the harmful effects of air pollution on cognitive performance in children.
I rarely report on drugs, but because I do have a number of early reports on the four drugs approved for use with Alzheimer’s, I wanted to provide this update.
The four drugs are donepezil, rivastigmine, galantamine and memantine. This review is said to be the first to rank their comparative safety and effectiveness. It used evidence from 142 clinical trials published between 1996 and 2015. The number of patients in each study ranged from 13 to 2,045, and the review evaluated a total of 33,889 patients.